NAD+ is one of the most studied molecules in modern biology. It powers hundreds of enzymes, fuels mitochondrial energy production, and switches on the sirtuin family of longevity genes. It is technically a dinucleotide, not a peptide, but it sits at the center of peptide and metabolism research alike.
What NAD+ Is
NAD+ stands for nicotinamide adenine dinucleotide. The plus sign refers to its oxidized form, the version that can accept electrons. Its molecular weight is about 663 g/mol, small by biological standards but mighty in scope.
Every living cell needs it. NAD+ is a cofactor for more than 500 enzymatic reactions. It moves electrons through metabolism the way a battery moves charge through a circuit, picking up electrons in one reaction and dropping them off in another.
How It Works in the Cell
The most familiar role of NAD+ is in mitochondrial oxidative phosphorylation. Here it shuttles electrons from food breakdown to the electron transport chain, which uses them to build ATP. Without enough NAD+, that chain stalls and cellular energy falls.
NAD+ also feeds three other major enzyme families. Sirtuins (SIRT1 through SIRT7) use NAD+ to remove chemical tags from proteins, which changes how genes are read and how mitochondria behave. PARPs use NAD+ to repair damaged DNA. CD38 and CD157 use it in calcium signaling and immune regulation.
This wide reach is why NAD+ shows up in so many research areas. It is a metabolic coenzyme, a longevity signal, a DNA-repair substrate, and an immune messenger all at once.
Why NAD+ Declines With Age
Tissue NAD+ levels drop as animals and humans age. Three trends drive this. First, the enzyme CD38 becomes more active in inflamed and aging tissue, and it consumes NAD+ at high rates. Second, synthesis pathways slow down, so the cell makes less new NAD+. Third, chronic DNA damage keeps PARPs busy, and busy PARPs eat through the NAD+ pool.
The consequences cascade. Gomes and colleagues (2013) showed that declining NAD+ disrupts SIRT1 signaling and creates a state of pseudohypoxia, where cells behave as if they are starved of oxygen even when oxygen is plentiful. Mitochondrial gene expression suffers as a result.
Restoring NAD+ has dramatic effects in animal models. Yoshino and colleagues (2011) reported that NAD+ restoration in aged mice normalized glucose tolerance and improved mitochondrial function. The work helped launch a wave of studies into NAD+ precursors and related compounds.
Research Frontiers
NAD+ research now spans aging, neurodegeneration, metabolic disease, cardiac repair, and immune function. Verdin (2015) reviewed NAD+ as a central regulator of aging and neurodegeneration, framing it as a hub where energy, repair, and gene expression meet.
Researchers explore several routes to support NAD+ levels. Some study direct NAD+ delivery in cell and animal models. Others look at precursors that the body converts into NAD+, or at inhibitors of CD38 and PARPs that slow NAD+ consumption. Each route asks slightly different questions about how the molecule moves between tissues.
The signaling angle is just as active. Sirtuins remain a major focus, especially SIRT1 and SIRT3, which sit at the crossroads of metabolism and mitochondrial quality control.
Open Questions
Plenty remains unsettled. Scientists still debate how well NAD+ levels in blood reflect levels inside specific tissues, whether long-term NAD+ elevation has unwanted effects on cell growth, and which precursors raise the pool most efficiently in different organs. Translating mouse results to human biology has been slower than early enthusiasm predicted.
Even with these gaps, NAD+ remains one of the most important molecules in modern aging and metabolism research. These compounds are sold strictly for in vitro laboratory research and are not approved for human consumption.